CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-29 | Mills Kenneth T. Director | Grant or award | +9,807 | 495,925 | ||
| 2026-05-29 | Mills Kenneth T. Director | Grant or award · Stock Options (Right to Buy) | +46,600 | 46,600 | ||
| 2026-01-27 | Mills Kenneth T. Director | Exercise or conversion | +225,000 | $13.09 | $2.9M | 707,871 |
| 2026-01-27 | Mills Kenneth T. Director | Shares withheld for taxes | −221,753 | $13.41 | $3.0M | 486,118 |
| 2026-01-27 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) | −225,000 | 225,000 | ||
| 2025-05-30 | Mills Kenneth T. Director | Grant or award | +7,768 | 482,871 | ||
| 2025-05-30 | Mills Kenneth T. Director | Grant or award · Stock Options (Right to Buy) | +39,815 | 39,815 | ||
| 2025-05-12 | Mills Kenneth T. Director | Exercise or conversion 10b5-1 | +20,602 | $3.76 | $77K | 495,705 |
| 2025-05-12 | Mills Kenneth T. Director | Sale 10b5-1 | −20,602 | $7.91 | $163K | 475,103 |
| 2025-05-12 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) 10b5-1 | −20,602 | 0 | ||
| 2025-03-27 | Mills Kenneth T. Director | Exercise or conversion | +30,752 | $3.76 | $116K | 475,103 |
| 2025-03-27 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) | −30,752 | 20,602 | ||
| 2024-08-08 | Mills Kenneth T. Director | Exercise or conversion | +36,316 | $0.85 | $31K | 444,351 |
| 2024-08-08 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) | −36,316 | 0 | ||
| 2024-07-25 | Mills Kenneth T. Director | Exercise or conversion 10b5-1 | +15,369 | $3.76 | $58K | 423,404 |
| 2024-07-25 | Mills Kenneth T. Director | Sale 10b5-1 | −15,369 | $13.96 | $215K | 408,035 |
| 2024-07-25 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) 10b5-1 | −15,369 | 51,354 | ||
| 2024-07-24 | Mills Kenneth T. Director | Exercise or conversion 10b5-1 | +12,221 | $3.76 | $46K | 420,256 |
| 2024-07-24 | Mills Kenneth T. Director | Sale 10b5-1 | −12,221 | $13.78 | $168K | 408,035 |
| 2024-07-24 | Mills Kenneth T. Director | Exercise or conversion · Stock Options (Right to Buy) 10b5-1 | −12,221 | 66,723 |
Page 1 of 11 · 219 trades